Assessment and treatment of social anxiety disorder

Professional Psychology: Research and Practice

Volumn 34, Issue 4, 2003, Pages 396-405

  Feldman, Lisa B ^a   Rivas Vazquez, Rafael A ^a  

^a Citrus Health Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0041377007     PISSN: 07357028     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7028.34.4.396     Document Type: Review

References (90)

1. Adolphs, R. (2001). The neurobiology of social cognition. Current Opinion in Neurobiology, 11, 231-239.
2. Adolphs, R., Tranel, D., & Damasio, A. R. (1998). The human amygdala in social judgment. Nature, 393, 470-474.
3. Albano, A. M., DiBartolo, P. M., Heimberg, R. G., & Barlow, D. H. (1995). Children and adolescents: Assessment and treatment. In R. G. Heimberg, M. R. Liebowitz, D. A. Hope, & F. R. Schneir (Eds.), Social phobia: Diagnosis, assessment and treatment (pp. 387-425). New York: Guilford Press.
4. Altamura, A. C., Pioloi, R., Vitto, M., & Mannu, P. (1999). Venlafaxine in social phobia: A study in selective serotonin reuptake inhibitor non-responders. International Journal of Clinical Psychopharmacology, 14, 239-245.
5. Amaral. D. G. (2002). The primate amygdala and the neurobiology of social behavior: Implications for understanding social anxiety. Biological Psychiatry, 51, 11-17.
6. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
7. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
8. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author.
9. Arbelle, S., Benjamin, J., Golin, M., Kremer, I., Belmaker, R. H., & Ebstein, R. P. (2003). Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism. American Journal of Psychiatry, 160, 671-676.
10. Argyropoulous, S. V., Bell, C. J., & Nutt, D. J. (2001). Brain function in social anxiety disorder. Psychiatric Clinics of North America, 24, 707-722.
11. Ballenger, J. C., Davidson, J. R., Lecrubier, Y., Nutt, D. J., Bobes. J., Beidel, D. C., Ono, Y., & Westenberg, H. G. (1998). Consensus statement on social anxiety disorder from the international consensus group on depression and anxiety. Journal of Clinical Psychiatry, 59, 54-60.
12. Beck, A. T. (1985). Anxiety disorders and phobias: A cognitive perspective. New York: Basic Books.
13. Beidel, D. C., & Turner, S. M. (1998). Shy children, phobic adults: Nature and treatment of social phobia. Washington, DC: American Psychological Association.
14. Beidel, D. C., Turner, S. M., & Morris, T. L. (1995). A new instrument to assess childhood social anxiety and phobia: The Social Phobia and Anxiety Inventory for Children. Psychological Assessment, 1, 73-79.
15. Beidel, D. C., Turner, S. M., & Morris, T. L. (2000). Behavioral treatment of childhood social phobia. Journal of Consulting and Clinical Psychology, 68, 1072-1080.
16. Bell, C. J., Malizia, A. L., & Nutt, D. J. (1999). The neurobiology of social phobia. European Archives of Psychiatry and Clinical Neuroscience, 249(Suppl. 1), 11-18.
17. Biederman, J., Hirshfeld-Becker, D. R., Rosenbaum, J. F., Herot, C., Friedman. D., Snidman, N., Kagan, J., & Faraone, S. V. (2001). Further evidence of association between behavioral inhibition and social anxiety in children. American Journal of Psychiatry, 158, 1673-1679.
18. Biais, M. A., Lenderking, W. R., Baer, L., deLorell, A., Peets, K., Leahy, L., & Burns, C. (1999). Development and initial validation of a brief mental health outcome measure. Journal of Personality Assessment, 73, 359-373.
19. Bobes, J. (1998). How is recovery from social anxiety disorder defined? Journal of Clinical Psychiatry, 59, 12-16.
20. Bodinger, L., Hermesh, H., Aizenberg, D., Valevski, A., Marom, S., Shiloh, R., Gothelf, D., Zemishlany, Z., & Weizman, A. (2002). Sexual function and behavior in social phobia. Journal of Clinical Psychiatry, 63, 874-879.
21. Bruch, M. (1989). Familial and developmental antecedents of social phobia: Issues and findings. Clinical Psychology Review, 9, 37-47.
22. Compton, S. N., Grant, P. J., Chrisman, A. K., Gammon, P. J., Brown, V. L., & March, J. S. (2001). Sertraline in children and adolescents with social anxiety disorder: An open trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 564-571.
23. Connor, K. M., Davidson, J. R., Churchill, L. E., Sherwood, A., Foa, E., & Weisler, R. H. (2000). Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. British Journal of Psychiatry, 176, 379-386.
24. Connor, K. M., Kobak, K. A., Churchill, L. E., Katzelnick, D., & Davidson, J. R. (2001). Mini-SPIN: A brief screening assessment of generalized social anxiety disorder. Depression and Anxiety, 14, 137-140.
25. Coupland, N. J. (2001). Social phobia: Etiology, neurobiology, and treatment. Journal of Clinical Psychiatry, 62(Suppl. 1), 25-35.
26. Fresco, D. M., Coles, M. E., Heimberg, R. G., Liebowitz, M. R., Hami, S., Stein, M. B., & Goetz, D. (2001). The Liebowitz Social Anxiety Scale: A comparison of the psychometric properties of self-report and clinician-administered formats. Psychological Medicine, 31, 1025-1035.
27. Frisch, M. B., Cornell, J., Villanueva, M., & Retzlaff, P. J. (1992). Clinical validation of the Quality of Life Inventory. A measure of life satisfaction for use in treatment planning and outcome assessment. Psychological Assessment, 4, 92-101.
28. Fyer, A. J., Mannuzza, S., Chapman, T. F., Liebowitz, M. R., & Klein, D. F. (1993). A direct interview family study of social phobia. Archives of General Psychiatry, 52, 564-573.
29. Gilbert. P. (2001). Evolution and social anxiety. The role of attraction, social competition, and social hierarchies. Psychiatric Clinics of North America, 24, 723-751.
30. Gould, R. A., Buckminstet, S., & Pollack. M. H. (1997). Cognitive-behavioral and pharmacological treatment for social phobia: A metaanalysis. Clinical Psychology: Science and Practice, 4, 291-306.
31. Heimberg, R. G., Homer, K. G., Juster, H. R., Safren, S. A., Brown, E. J., Schneier, F. R., & Liebowitz, M. R. (1999). Psychometric properties of the Liebowitz Social Anxiety Scale. Psychological Medicine, 29, 199-212.
32. Heimberg, R. G., Juster, H. R., & Hope, D. A. (1995). Cognitive behavioral group treatment for social phobia; Description, case presentation, and empirical support. In M. B. Stein (Ed.), Social Phobia: Clinical and research perspectives (pp. 293-321). Washington, DC: American Psychiatric Press.
33. Heimberg, R. G., Liebowitz, M. R., Hope, D. A., Schneier, F. R., Holt, C. S., Welkowitz, L. A., et al. (1998). Cognitive behavioral group therapy vs. phenelzine therapy for social phobia: 12-week outcome. Archives of General Psychiatry, 55, 1133-1141.
34. Heimberg, R. G., Salzman, D. G., Holt, C. S., & Blendeil, K. A. (1993). Cognitive behavioral group treatment for social phobia: Effectiveness at five-year follow-up. Cognitive Therapy Research, 17, 325-339.
35. Hymel, S., Rubin, K., Rowden, L., & LeMare, L. (1990). Children's peer relationships: Longitudinal prediction of internalizing and externalizing problems from middle to late childhood. Child Development, 61, 2004-2021.
36. Inderbitzen-Nolan, H. M., & Walters, K. S. (2000). Social Anxiety Scale for Adolescents: Normative data and further evidence of construct validity. Journal of Clinical Child Psychology, 29, 360-371.
37. Jefferson, J. W. (2001). Benzodiazepines and anticonvulsants for social phobia (social anxiety disorder). Journal of Clinical Psychiatry, 62(Suppl. 1), 50-53.
38. Kagan, J., Reznick, J. S., & Snidman, N. (1987). The physiology and psychology of behavioral inhibition in children. Child Development, 58, 1459-1473.
39. Katzelnick, D. J., & Greist, J. H. (2001). Social anxiety disorder: An unrecognized problem in primary care. Journal of Clinical Psychiatry, 62, 11-15.
40. Katzelnick, D. J., Kobak, K. A., DeLeire, T., Henk, H. J., Greist, J. H., Davidson, J. R. T., et al. (2001). Impact of generalized social anxiety disorder in managed care. American Journal of Psychiatry, 158, 1999-2007.
41. Katzelnick, D. J., Kobak, K. A., Greist, J. H., Jefferson, J. W., Mantle, J. M., & Serlin, R. C. (1995). Sertraline for social phobia: A double-blind, placebo-controlled crossover study. American Journal of Psychiatry, 152, 1368-1371.
42. Kelsey, J. E. (1995). Venlafaxine in social phobia. Psychopharmacology Bulletin, 31, 767-771.
43. Kobak, K. A., Greist, J. H., Jefferson, J. W., & Katzelnick, D. J. (2002). Fluoxetine in social phobia: A double-blind, placebo-controlled pilot study. Journal of Clinical Psychopharmacology, 22, 257-262.
44. Kobak, K. A., Schaettle, S. C., Greist, J. H., Jefferson, J. W., Katzelnick, D. J., & Dottl, S. L. (1998). Computer-administered rating scales for social anxiety in a clinical drug trial. Depression and Anxiety, 7, 97-104.
45. Kulpa, J. (2003). Venlafaxine, sertraline approved for social anxiety. CNS News, 5, 58.
46. La Greca, A. M., & Lopez, N. (1998), Social anxiety among adolescents: Linkages with peer relations and friendships. Journal of Clinical Child Psychology, 17, 84-91.
47. La Greca, A. M., & Stone, W. L. (1993). Social Anxiety Scale for Children - Revised: Factor structure and concurrent validity. Journal of Clinical Child Psychology, 22, 17-27.
48. Lang, A. J., & Stein, M. B. (2001). Social phobia: Prevalence and diagnostic threshold. Journal of Clinical Psychiatry, 62, 5-10.
49. Lecrubier, Y. (1998). Comorbidity in social anxiety disorder: Impact on disease burden and management. Journal of Clinical Psychiatry, 59, 33-37.
50. Lee, G. P., Bechara, A., Adolphs, R., Arena, J., Meador, K. J., Loring, D. W., & Smith, J. R. (1998). Clinical and physiological effects of stereotaxic bilateral amygdalotomy for intractable aggression. Journal of Neuropsychiatry and Clinical Neurosciences, 10, 413-420.
51. Leon, A. C., Shear, M. K., & Portera, L. (1992). Assessing impairment in patients with panic disorder: The Sheehan Disability Scale. Social Psychiatry and Psychiatric Epidemiology, 27, 78-82.
52. Lepine, J. P. (2002). The epidemiology of anxiety disorders: Prevalence and societal costs. Journal of Clinical Psychiatry, 63(Suppl. 14), 4-8.
53. Liebowitz, M. R. (1987). Social phobia. Modern Problems of Pharma-copsychiatry, 22, 141-173.
54. Liebowitz, M. R., Heimberg, R. G., Fresco, D. M., Travers, J., & Stein, M. B. (2000). Social phobia or social anxiety disorder: What's in a name? Archives of General Psychiatry, 57, 191-192.
55. Liebowitz, M. R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., et al. (1992). Phenelzine versus atenolol in social phobia. A placebo-controlled comparison. Archives of General Psychiatry, 49, 290-300.
56. Liebowitz, M. R., Stein, M. B., Tancer, M., Carpenter, D., Oakes, R., & Pitts, C. D. (2002). A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. Journal of Clinical Psychiatry, 63, 66-74.
57. Lydiard, R. B. (2001). Social anxiety disorder: Comorbidity and its implications. Journal of Clinical Psychiatry, 62, 17-23.
58. Mannuzza, S., Schneier, F., Chapman, T. F., Liebowitz, M. R., Klein, D. F., & Fyer, A. J. (1995). Generalized social phobia: Reliability and validity. Archives of General Psychiatry, 52, 230-237.
59. Masia, C. L., Hofmann, S. G., Klein R. G., & Liebowitz, M. R. (1999). The Liebowitz Social Anxiety Scale for Children and Adolescents (LSAS - CA). (Available from Carrie L. Masia, PhD, NYU Child Study Center, 550 First Avenue, New York, NY 10016)
60. Masia, C. L., Klein, R. G., Storch, E. A., & Corda, B. (2001). School-based behavioral treatments for social anxiety disorder in adolescents: Results of a pilot study. American Academy of Child and Adolescent Psychiatry, 40, 780-786.
61. Mathew, S. J., Coplan, J. D., & Gorman, J. M. (2001). Neurobiological mechanisms of social anxiety disorder. American Journal of Psychiatry, 158, 1558-1567.
62. Moutier, C. Y., & Stein, M. B. (1999). The history, epidemiology, and differential diagnosis of social anxiety disorder. Journal of Clinical Psychiatry, 60, 4-8.
63. Muris, P., Merckelbach, H., & Damsma, E. (2000). Threat perception bias in nonreferred, socially anxious children. Journal of Clinical Child Psychology, 29, 348-359.
64. Olfson, M., Guardino, M., Struening, E., Schneier, F. R., Hellman, F., & Klein, D. F. (2000). Barriers to the treatment of social anxiety. American Journal of Psychiatry, 157, 521-527.
65. Ollendick, T. H., & Hirshfeld-Becker, D. R. (2002). The developmental psychopathology of social anxiety disorder. Society of Biological Psychiatry, 51, 44-58.
66. Otto, M. W. (1999). Cognitive-behavioral therapy for social anxiety disorder: Model, methods, and outcome. Journal of Clinical Psychiatry, 60, 14-19.
67. Pande, A. C., Davidson, J. R., Jefferson, J. W., Janney, C. A., Katzelnick, D. J., Weisler, R. H., et al. (1999). Treatment of social phobia with gabapentin: A placebo-controlled study. Journal of Clinical Psychopharmacology, 19, 341-348.
68. Pollack, M. H. (1999). Social anxiety disorder: Designing a pharmacologie treatment strategy. Journal of Clinical Psychiatry, 60(Suppl. 9), 20-26.
69. Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993). The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics, 4, 353-365.
70. Rosenbaum, J. F., Biederman, J., Pollock, R. A., & Hirshfeld, D. R. (1994). The etiology of social phobia. Journal of Clinical Psychiatry, 55, 10-16.
71. Schneier, F. R. (2001). Treatment of social phobia with antidepressants. Journal of Clinical Psychiatry, 63(Suppl. 1), 43-48.
72. Schneier, F. R., Heckelman, L. R., Garfinkel, R., Campeas, R., Fallen, B. A., Gitow, A., et al. (1994). Functional impairment in social phobia. Journal of Clinical Psychiatry, 55, 322-331.
73. Schneier, F. R., Johnson, J., Hornig, C. D., Liebowitz, M. R., & Weissman, M. M. (1992). Social phobia: Comorbidity and morbidity in an epidemiological sample. Archives of General Psychiatry, 49, 282-288.
74. Simon, N. M., Otto, M. W., Korbly, N. B., Peters, P. M., Nicolaou, D. C., & Pollack, M. H. (2002). Quality of life in social anxiety disorder compared with panic disorder and the general population. Psychiatric Services, 53, 714-718.
75. Spence, S. H. (1995). Social skills training; Enhancing social competence with children and adolescents, Windsor, England: NFER-Nelson.
76. Spence, S. H., Donovan, C., & Brechman-Toussaint, M. (1999). Social skills, social outcomes, and cognitive features of childhood social phobia. Journal of Abnormal Psychology, 108, 211-221.
77. Stein, D. J., Stein, M. B., Pitts, C. D., Kumar, R., & Hunter, B. (2002). Predictors of response to pharmacotherapy in social anxiety disorder: An analysis of 3 placebo-controlled -paroxetine trials. Journal of Clinical Psychiatry, 63, 152-155.
78. Stein, D. J., Westenberg, H. G. M., & Liebowitz, M. R. (2002). Social anxiety disorder and generalized anxiety disorder: Serotonergic and dopaminergic neurocircuitry. Journal of Clinical Psychiatry, 63(Suppl. 6), 12-19.
79. Stein, M. B., Fuetsch, M., Muller, N., Hofler, M., Live, R., & Wittchen, H. U. (2001). Social anxiety disorder and risk of depression: A prospective community study of adolescents and young adults. Archives of General Psychiatry, 58, 251-256.
80. Stein, M. B., Fyer, A. J., Davidson, J. R., Pollack, M. H., & Wiita, B. (1999). Fluvoxamine treatment of social phobia (social anxiety disorder): A double-blind, placebo-controlled study. American Journal of Psychiatry, 156, 756-760.
81. Stein, M. B., Jang, K. L., & Livesly, W. J. (2002). Heritability of social anxiety-related concerns and personality characteristics: A twin study. Journal of Nervous and Mental Diseases, 190, 219-224.
82. Stein, M. B., Liebowitz, M. R., Lydiard, R. B., Pitts, C. D., Bushnell, W., & Gergel, I. (1998). Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial. JAMA, 280, 708-713.
83. Stemberger, R., Turner, S., Beidel, D., & Calhoun, K. (1995). Social phobia: An analysis of possible developmental factors. Journal of Abnormal Psychology, 104, 526-531.
84. Turner, S. M., Beidel, D. C., Cooley, M. R., Woody, S. R., & Messer, S. C. (1994). A multicomponent behavioral treatment for social phobia: Social effectiveness therapy. Behaviour Research and Therapy, 32, 381-390.
85. Van Ameringen, M. A., Lane, R. M., Walker, J. R., Bowen, R. C., Chokka, P. R., & Goldner, E. M. (2001). Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study. American Journal of Psychiatry, 158, 275-281.
86. Van Ameringen, M., Mancini, C., & Oakman, J. M. (1999). Nefazodone in social phobia. Journal of Clinical Psychiatry, 60, 96-100.
87. Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): Conceptual framework and item selection. Medical Care, 30, 473-483.
88. Westenberg, H. G. M. (1998). The nature of social anxiety disorder. Journal of Clinical Psychiatry, 59, 20-24.
89. Wittchen, H. U., & Beloch, E. (1996). The impact of social phobia on quality of life. International Clinical Psychopharmacology, 11(Suppl. 3), 15-23.
90. Worthington, J. J., Zucker, B. G., Fones, C. S., Otto, M. W., & Pollack, M. H. (1998). Nefazodone for social phobia: A clinical case series. Depression and Anxiety, 8, 131-133.